Notice of Final Results and Investor Presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SAR notes
Cambridge, UK, 23 October 2024 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, will announce its financial results for the year ended 30 June 2024 on Tuesday, 29 October 2024.
The Company will also be holding a live presentation to investors on Tuesday, 29 October 2024 at 14:30 GMT via the Investor Meet Company platform.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 28 Oct 2024, 09:00 GMT, or at any time during the live presentation.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.